Advertisement
Screener

SPYRE THERAPEUTICS, INC. (SYRE) Net Margin

SPYRE THERAPEUTICS, INC. (SYRE) Net Margin

  • 2023-06-30: Net Margin -31552.47%.
  • 2023-03-31: Net Margin -9304.04%.
  • 2022-12-31: Net Margin -11203.57%.
  • 2022-09-30: Net Margin -10479.31%.

Complete source-backed net margin history.

Available history
2016-12-31 to 2023-12-31
Data captured

Historical Net Margin

DateNet Margin
2023-06-30-31552.47%
2023-03-31-9304.04%
2022-12-31-11203.57%
2022-09-30-10479.31%
2022-06-30-3571.68%
2022-03-31-1794.13%
2021-12-31-561.09%
2021-09-30-1451.54%
2021-06-30-49.87%
2018-06-30-395.88%
2018-03-31-537.68%
2017-12-31-437.45%
2017-09-30-624.43%
2017-06-30-448.41%

Annual Net Margin

DateNet Margin
2023-12-31-38238.15%
2022-12-31-3598.75%
2021-12-31-351.14%
2018-12-31-1140.64%
2017-12-31-523.27%
2016-12-31-468.84%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Alkermes plc. (ALKS)$6.844B132.74
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
CYTOKINETICS INC (CYTK)United States$9.130B-11.86